"Study demonstrated that Fcmr (Toso) the putative receptor for soluble IgM modulates myeloid cell responses to cancer. In a syngeneic melanoma model Fcmr ablation in myeloid cells suppressed tumor growth and extended mouse survival. Fcmr deficiency increased myeloid cell population density in this malignancy and enhanced anti-tumor immunity."xsd:string